Injectable opioid agonist treatment (iOAT) for opioid use disorder: National clinical guideline | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Home » Resources » Injectable opioid agonist treatment (iOAT) for opioid use disorder: National clinical guideline

Published by:	Canadian Research Initiative in Substance Misuse (CRISM)
Date:	2019
Type:	Guideline or manual
Language(s):	English, French
Topic(s):	Harm reduction and substance use > Safer substance use
Programming:	Health care delivery
Access:	Read it online

Events

Conference on Retroviruses and Opportunistic Infections (CROI)

International Antiviral Society – USA
March 6 to 10, 2021
Online

Canadian Liver Meeting 2021

Canadian Association for the Study of the Liver, the Canadian Network on Hepatitis C (CanHepC) and the Canadian Association of Hepatology Nurses
May 2 to May 5, 2021
Online

CAHR 2021

Canadian Association for HIV Research
May 5 to 7, 2021
Online

IAS Conference on HIV Science

International AIDS Society
July 18 to 21, 2021
Online

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.